Dataset Information

A method to acquire CT organ dose map using OSL dosimeters and ATOM anthropomorphic phantoms.

ABSTRACT: To present the design and procedure of an experimental method for acquiring densely sampled organ dose map for CT applications, based on optically stimulated luminescence (OSL) dosimeters "nanoDots" and standard ATOM anthropomorphic phantoms; and to provide the results of applying the method--a dose data set with good statistics for the comparison with Monte Carlo simulation result in the future.A standard ATOM phantom has densely located holes (in 3×3 cm or 1.5×1.5 cm grids), which are too small (5 mm in diameter) to host many types of dosimeters, including the nanoDots. The authors modified the conventional way in which nanoDots are used, by removing the OSL disks from the holders before inserting them inside a standard ATOM phantom for dose measurements. The authors solved three technical difficulties introduced by this modification: (1) energy dependent dose calibration for raw OSL readings; (2) influence of the brief background exposure of OSL disks to dimmed room light; (3) correct pairing between the dose readings and measurement locations. The authors acquired 100 dose measurements at various positions in the phantom, which was scanned using a clinical chest protocol with both angular and z-axis tube current modulations.Dose calibration was performed according to the beam qualities inside the phantom as determined from an established Monte Carlo model of the scanner. The influence of the brief exposure to dimmed room light was evaluated and deemed negligible. Pairing between the OSL readings and measurement locations was ensured by the experimental design. The organ doses measured for a routine adult chest scan protocol ranged from 9.4 to 18.8 mGy, depending on the composition, location, and surrounding anatomy of the organs. The dose distribution across different slices of the phantom strongly depended on the z-axis mA modulation. In the same slice, doses to the soft tissues other than the spinal cord demonstrated relatively small variations, with the maximum COV around 11.4%. This might be attributed to the angular mA modulation, the placement of the dosimeters, the chest cavity of the scanned region, and the size of the phantom. Doses to the spinal cord were consistently lower than those to other soft tissues.The method is suited for acquiring densely sampled organ dose maps, and can be used for studying dose distributions relevant to subject size, organ location, and clinical CT protocols.

SUBMITTER: Zhang D

PROVIDER: S-EPMC3739834 | biostudies-other | 2013 Aug

REPOSITORIES: biostudies-other

ACCESS DATA

Similar Datasets

Project description:The aims of this study were to characterize reinforced metal-oxide-semiconductor field-effect transistor (MOSFET) dosimeters to assess the measurement uncertainty, single exposure low-dose limit with acceptable accuracy, and the number of exposures required to attain the corresponding limit of the thermoluminescent dosimeters (TLD). The second aim was to characterize MOSFET dosimeter sensitivities for two dental photon energy ranges, dose dependency, dose rate dependency, and accumulated dose dependency. A further aim was to compare the performance of MOSFETs with those of TLDs in an anthropomorphic phantom head using a dentomaxillofacial CBCT device. The uncertainty was assessed by exposing 20 MOSFETs and a Barracuda MPD reference dosimeter. The MOSFET dosimeter sensitivities were evaluated for two photon energy ranges (50-90 kVp) using a constant dose and polymethylmethacrylate backscatter material. MOSFET and TLD comparative point-dose measurements were performed on an anthropomorphic phantom that was exposed with a clinical CBCT protocol. The MOSFET single exposure low dose limit (25% uncertainty, k = 2) was 1.69 mGy. An averaging of eight MOSFET exposures was required to attain the corresponding TLD (0.3 mGy) low-dose limit. The sensitivity was 3.09 ± 0.13 mV/mGy independently of the photon energy used. The MOSFET dosimeters did not present dose or dose rate sensitivity but, however, presented a 1% decrease of sensitivity per 1000 mV for accumulated threshold voltages between 8300 mV and 17500 mV. The point doses in an anthropomorphic phantom ranged for MOSFETs between 0.24 mGy and 2.29 mGy and for TLDs between 0.25 and 2.09 mGy, respectively. The mean difference was -8%. The MOSFET dosimeters presented statistically insignificant energy dependency. By averaging multiple exposures, the MOSFET dosimeters can achieve a TLD-comparable low-dose limit and constitute a feasible method for diagnostic dosimetry using anthropomorphic phantoms. However, for single in vivo measurements (<1.7 mGy) the sensitivity is too low.

Project description:PURPOSE:To design volume-specific breast phantoms from breast CT (bCT) data sets and estimate the associated normalized mean glandular dose coefficients for breast CT using Monte Carlo methods. METHODS:A large cohort of bCT data sets (N = 215) was used to evaluate breast volume into quintiles (plus the top 5%). The average radius profile was then determined for each of the six volume-specific groups and used to both fabricate physical phantoms and generate mathematical phantoms (V1-V6; "V" denotes classification by volume). The MCNP6 Monte Carlo code was used to model a prototype bCT system fabricated at our institution; and this model was validated against physical measurements in the fabricated phantoms. The mathematical phantoms were used to simulate normalized mean glandular dose coefficients for both monoenergetic source photons "DgNCT (E)" (8-70 keV in 1 keV intervals) and polyenergetic x-ray beams "pDgNCT " (35-70 kV in 1 kV intervals). The Monte Carlo code was used to study the influence of breast size (V1 vs. V5) and glandular fraction (6.4% vs. 45.8%) on glandular dose. The pDgNCT coefficients estimated for the V1, V3, and V5 phantoms were also compared to those generated using simple, cylindrical phantoms with equivalent volume and two geometrical constraints including; (a) cylinder radius determined at the breast phantom chest wall "Rcw "; and (b) cylinder radius determined at the breast phantom center-of-mass "RCOM ". RESULTS:Satisfactory agreement was observed for dose estimations using MCNP6 compared with both physical measurements in the V1, V3, and V5 phantoms (R2 = 0.995) and reference bCT dose coefficients using simple phantoms (R2 = 0.999). For a 49 kV spectrum with 1.5 mm Al filtration, differences in glandular fraction [6.5% (5th percentile) vs. 45.8% (95th percentile)] had a 13.2% influence on pDgNCT for the V3 phantom, and differences in breast size (V1 vs. V5) had a 16.6% influence on pDgNCT for a breast composed of 17% (median) fibroglandular tissue. For cylindrical phantoms with a radius of RCOM , the differences were 1.5%, 0.1%, and 2.1% compared with the V1, V3, and V5 phantoms, respectively. CONCLUSION:Breast phantoms were designed using a large cohort of bCT data sets across a range of six breast sizes. These phantoms were then fabricated and used for the estimation of glandular dose in breast CT. The mathematical phantoms and associated glandular dose coefficients for a range of breast sizes (V1-V6) and glandular fractions (5th to 95th percentiles) are available for interested users.

Project description:Purpose To develop a method to incorporate the propagation of contrast material into computational anthropomorphic phantoms for estimation of organ dose at computed tomography (CT). Materials and Methods A patient-specific physiologically based pharmacokinetic (PBPK) model of the human cardiovascular system was incorporated into 58 extended cardiac-torso (XCAT) patient phantoms. The PBPK model comprised compartmental models of vessels and organs unique to each XCAT model. For typical injection protocols, the dynamics of the contrast material in the body were described according to a series of patient-specific iodine mass-balance differential equations, the solutions to which provided the contrast material concentration time curves for each compartment. Each organ was assigned to a corresponding time-varying iodinated contrast agent to create the contrast material-enhanced five-dimensional XCAT models, in which the fifth dimension represents the dynamics of contrast material. To validate the accuracy of the models, simulated aortic and hepatic contrast-enhancement results throughout the models were compared with previously published clinical data by using the percentage of discrepancy in the mean, time to 90% peak, peak value, and slope of enhancement in a paired t test at the 95% significance level. Results The PBPK model allowed effective prediction of the time-varying concentration curves of various contrast material administrations in each organ for different patient models. The contrast-enhancement results were in agreement with results of previously published clinical data, with mean percentage, time to 90% peak, peak value, and slope of less than 10% (P > .74), 4%, 7%, and 14% for uniphasic and 12% (P > .56), 4%, 12%, and 14% for biphasic injection protocols, respectively. The exception was hepatic enhancement results calculated for a uniphasic injection protocol for which the discrepancy was less than 25%. Conclusion A technique to model the propagation of contrast material in XCAT human models was developed. The models with added contrast material propagation can be applied to simulate contrast-enhanced CT examinations. © RSNA, 2017 Online supplemental material is available for this article.

Project description:PurposeThe risk of inducing cancer to patients undergoing CT examinations has motivated efforts for CT dose estimation, monitoring, and reduction, especially among pediatric population. The method investigated in this study is Acuros CTD (Varian Medical Systems, Palo Alto, CA), a deterministic linear Boltzmann transport equation (LBTE) solver aimed at generating rapid and reliable dose maps of CT exams. By applying organ contours, organ doses can also be obtained, thus patient-specific organ dose estimates can be provided. This study experimentally validated Acuros against measurements performed on a clinical CT system using a range of physical pediatric anthropomorphic phantoms and acquisition protocols.MethodsThe study consisted of (1) the acquisition of dose measurements on a clinical CT scanner through thermoluminescent dosimeters (TLDs), and (2) the modeling in the Acuros platform of the measurement set up, which includes the modeling of the CT scanner and of the anthropomorphic phantoms. For the measurements, 1-year-old, 5-year-old, and 10-year-old anthropomorphic phantoms of the CIRS ATOM family were used. TLDs were placed in selected organ locations such as stomach, liver, lungs, and heart. The pediatric phantoms were scanned helically with the GE Discovery 750 HD clinical scanner for several examination protocols. For the simulations in Acuros, scanner-specific input, such as bowtie filters, overrange collimation, and tube current modulation schemes, were modeled. These scanner complexities were implemented by defining discretized X-ray beams whose spectral distribution, defined in Acuros by only six energy bins, varied across fan angle, cone angle, and slice position. The images generated during the CT acquisitions were used to create the geometrical models, by applying thresholding algorithms and assigning materials to the HU values. The TLDs were contoured in the phantom models as sensitive cylindrical volumes at the locations selected for dosimeters placement, to provide dose estimates, in terms of dose per unit photon. To compare measured doses with dose estimates, a calibration factor was derived from the CTDIvol displayed by the scanner, to account for the number of photons emitted by the X-ray tube during the procedure.ResultsThe differences of the measured and estimated doses, in terms of absolute % errors, were within 13% for 153 TLD locations, with an error of 17% at the stomach for one study with the 10-year-old phantom. Root-mean-squared-errors (RMSE) across all TLD locations for all configurations were in the range of 3%-8%, with Acuros providing dose estimates in a time range of a few seconds up to 2 min.ConclusionsAn overall good agreement between measurements and simulations was achieved, with average RMSE of 6% across all cases. The results demonstrate that Acuros can model a specific clinical scanner despite the required discretization in spatial and energy domains. The proposed deterministic tool has the potential to be part of a near real-time individualized dosimetry monitoring system for CT applications, providing patient-specific organ dose estimates.

Project description:ObjectivesTo assess how modifying multiple protocol parameters affects the dose and diagnostic performance of a neck CT protocol using patient-mimicking phantoms and task-based methods.MethodsSix patient-mimicking neck phantoms containing hypodense lesions of 1 cm diameter and 30 HU contrast and one non-lesion phantom were examined with 36 CT protocols. All possible combinations of the following parameters were investigated: 100- and 120-kVp tube voltage; tube current modulation (TCM) noise levels of SD 7.5, 10, and 14; pitches of 0.637, 0.813, and 1.388; filtered back projection (FBP); and iterative reconstruction (AIDR 3D). Dose-length products (DLPs) and lesion detectability (assessed by 14 radiologists) were compared with the clinical standard protocol (120 kVp, TCM SD 7.5, 0.813 pitch, AIDR 3D).ResultsThe DLP of the standard protocol was 25 mGy•cm; the area under the curve (AUC) was 0.839 (95%CI: 0.790-0.888). Combined effects of tube voltage reduction to 100 kVp and TCM noise level increase to SD 10 optimized protocol performance by improving dose (7.3 mGy•cm) and detectability (AUC 0.884, 95%CI: 0.844-0.924). Diagnostic performance was significantly affected by the TCM noise level at 120 kVp (AUC 0.821 at TCM SD 7.5 vs. 0.776 at TCM SD 14, p = 0.003), but not at 100-kVp tube voltage (AUC 0.839 at TCM SD 7.5 vs. 0.819 at TCM SD 14, p = 0.354), the reconstruction method at 100 kVp (AUC 0.854 for AIDR 3D vs. 0.806 for FBP, p < 0.001), but not at 120-kVp tube voltage (AUC 0.795 for AIDR 3D vs. 0.793 for FBP, p = 0.822), and the tube voltage for AIDR 3D reconstruction (p < 0.001), but not for FBP (p = 0.226).ConclusionsCombined effects of 100-kVp tube voltage, TCM noise level of SD 10, a pitch of 0.813, and AIDR 3D resulted in an optimal neck protocol in terms of dose and diagnostic performance. Protocol parameters were subject to complex interactions, which created opportunities for protocol improvement.Key points• A task-based approach using patient-mimicking phantoms was employed to optimize a CT system for neck imaging through systematic testing of protocol parameters. • Combined effects of 100-kVp tube voltage, TCM noise level of SD 10, a pitch of 0.813, and AIDR 3D reconstruction resulted in an optimal protocol in terms of dose and diagnostic performance. • Interactions of protocol parameters affect diagnostic performance and should be considered when optimizing CT techniques.

Dataset Information

A method to acquire CT organ dose map using OSL dosimeters and ATOM anthropomorphic phantoms.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets